We are live on
!
Find out more
AB
Amalgamated Bank Portfolio holdings
AUM
$14.5B
1-Year Est. Return
44.3%
This Fund
S&P 500
This Quarter
Est. Return
-3%
1 Year Est. Return
+44.3%
3 Year Est. Return
+131.76%
5 Year Est. Return
+175.18%
10 Year Est. Return
+715.35%
AUM
$12.9B
AUM Growth
-$678M
(-5%)
Cap. Flow
+$6.37M
Cap. Flow
% of AUM
0.05%
Top 10 Holdings %
Top 10 Hldgs %
23.8%
Holding
3,083
New
921
Increased
335
Reduced
1,799
Closed
24
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Accenture
ACN
|
+$60.7M |
| 2 |
Medtronic
MDT
|
+$35.8M |
| 3 |
Apple
AAPL
|
+$30.8M |
| 4 |
Microsoft
MSFT
|
+$28.5M |
| 5 |
Linde
LIN
|
+$24.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$21M |
| 2 |
iShares Russell 3000 ETF
IWV
|
+$15.3M |
| 3 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$13.9M |
| 4 |
XLNX
Xilinx Inc
XLNX
|
+$13.2M |
| 5 |
Berkshire Hathaway Class B
BRK.B
|
+$10M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.64% |
| 2 | Financials | 13.28% |
| 3 | Healthcare | 13.15% |
| 4 | Consumer Discretionary | 12.03% |
| 5 | Industrials | 9.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1451
US Physical Therapy
USPH
$1.2B
| $630K | ﹤0.01% |
6,332
-340
| -5% | -$32.4K |
|
1452
Leslie's
LESL
$8.9M
| $629K | ﹤0.01% |
1,623
+260
| +19% | +$108K |
|
1453
WIX.com
WIX
$2.3B
| $628K | ﹤0.01% |
6,011
+1,300
| +28% | +$142K |
|
1454
Shift4
FOUR
$4.2B
| $627K | ﹤0.01% |
10,130
+1,047
| +12% | +$55.2K |
|
1455
Beyond Meat
BYND
$292M
| $626K | ﹤0.01% |
12,949
+1,008
| +8% | +$55.4K |
|
|
ADAM
1456
Adamas Trust
ADAM
$815M
| $622K | ﹤0.01% |
42,635
-1,912
| -4% | -$27.9K |
|
|
SLCA
1457
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $617K | ﹤0.01% |
33,068
-1,981
| -6% | -$25K |
|
1458
Zurn Elkay Water Solutions
ZWS
$8.38B
| $616K | ﹤0.01% |
17,403
-1,302
| -7% | -$43.3K |
|
1459
Veeco
VECO
$3.05B
| $615K | ﹤0.01% |
22,613
-1,131
| -5% | -$31.9K |
|
1460
e.l.f. Beauty
ELF
$4.89B
| $610K | ﹤0.01% |
23,614
-1,148
| -5% | -$31.2K |
|
1461
Century Aluminum
CENX
$4.43B
| $609K | ﹤0.01% |
23,149
-924
| -4% | -$19.4K |
|
|
CDMO
1462
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
| $609K | ﹤0.01% |
29,885
-1,054
| -3% | -$21.5K |
|
1463
Blackstone Mortgage Trust
BXMT
$2.45B
| $608K | ﹤0.01% |
19,130
-1,229
| -6% | -$38.6K |
|
1464
Ambarella
AMBA
$3.77B
| $607K | ﹤0.01% |
5,785
-415
| -7% | -$52.9K |
|
1465
Amphastar Pharmaceuticals
AMPH
$879M
| $607K | ﹤0.01% |
16,909
-1,024
| -6% | -$29K |
|
1466
Portland General Electric
POR
$5.71B
| $604K | ﹤0.01% |
10,946
-725
| -6% | -$38.1K |
|
|
BPMC
1467
DELISTED
Blueprint Medicines
BPMC
| $601K | ﹤0.01% |
9,415
-707
| -7% | -$50.7K |
|
1468
Sturm, Ruger & Co
RGR
$594M
| $599K | ﹤0.01% |
8,602
-252
| -3% | -$17.4K |
|
1469
CoreCivic
CXW
$2.96B
| $598K | ﹤0.01% |
53,548
-2,232
| -4% | -$21.8K |
|
1470
Enanta Pharmaceuticals
ENTA
$366M
| $598K | ﹤0.01% |
8,396
-352
| -4% | -$22.9K |
|
1471
Marcus & Millichap
MMI
$1.16B
| $595K | ﹤0.01% |
11,304
-444
| -4% | -$21.3K |
|
1472
OFG Bancorp
OFG
$2.23B
| $594K | ﹤0.01% |
22,309
-1,235
| -5% | -$34.3K |
|
1473
Regenxbio
RGNX
$620M
| $593K | ﹤0.01% |
17,854
-1,022
| -5% | -$28.4K |
|
1474
Sprout Social
SPT
$516M
| $593K | ﹤0.01% |
7,404
-530
| -7% | -$36.3K |
|
1475
Mesa Laboratories
MLAB
$557M
| $591K | ﹤0.01% |
2,317
-113
| -5% | -$30.7K |
|
Similar funds
JFG
IFP
BBVA
SSA
BGC
FGP
Amalgamated Bank's Q1 2022 Portfolio in Review
As of Q1 2022, Amalgamated Bank held 3,083 positions worth $12.9B, down 5% from $13.5B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
Amalgamated Bank's Q1 2022 filing shows 921 new, 335 increased, 1,799 reduced and 24 closed positions. Its largest new stake was Accenture: 180,111 shares worth $60.7M. The largest sale was iShares Core S&P 500 ETF, an estimated $21M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Financials and Healthcare.
- Amalgamated Bank's largest Q1 2022 buy was Accenture: 180,111 shares worth $60.7M.
- Amalgamated Bank added most to Apple in Q1 2022, an estimated $30.8M increase.
- Amalgamated Bank's biggest Q1 2022 reduction was iShares Core S&P 500 ETF, cutting an estimated $21M.
- Amalgamated Bank fully exited iShares Russell 3000 ETF in Q1 2022, selling an estimated $15.3M.
- Amalgamated Bank's ten largest holdings make up 24% of its $12.9B portfolio in Q1 2022.
- Amalgamated Bank opened 921 new positions and closed 24 in Q1 2022.
- Amalgamated Bank's portfolio value fell 5% quarter-over-quarter to $12.9B.
Based on Amalgamated Bank's 13F filing for Q1 2022, filed 30 Jun 2022.